Use of 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and cardiac sarcoidosis

Back

EHRA Premium Access

Use of 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and cardiac sarcoidosis

Session: Clinical: prevention

Topic: Clinical

Speaker: Doctor S. Costa (Zurich, CH)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Sarah Costa

University Hospital Zurich, Zurich (Switzerland)

0 follower

6 more presentations in this session

Nationwide burden of sudden cardiac death among patients with a psychiatric disorder

Speaker: Doctor J. Mujkanovic (Copenhagen, DK)

Family issues in invasive electrophysiology - career paths of female and male EP fellows in Germany

Speaker: Doctor J. Mueller-Leisse (Hannover, DE)

New joint model for the dynamic prediction of heart failure in phospholamban (PLN) p.(Arg14del) positive individuals

Speaker: Miss M. Van Der Heide (Amsterdam, NL)

Coexistence of cardiac sarcoidosis and genetic cardiomyopathies: a conundrum

Speaker: Doctor V. Rossi (Zurich, CH)

Primary prevention of atrial fibrillation with pharmacological therapy

Speaker: Mr K. Raveendra (Leeds, GB)

Access the full session

Clinical: prevention

Speakers: Doctor S. Costa, Doctor J. Mujkanovic, Doctor J. Mueller-Leisse, Miss M. Van Der Heide, Doctor V. Rossi...

Access

Video

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources